Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Cash from Investing Activities (2016 - 2023)

Tenax Therapeutics' Cash from Investing Activities history spans 8 years, with the latest figure at $1.1 million for Q4 2017.

  • On a quarterly basis, Cash from Investing Activities fell 90.93% to $1.1 million in Q4 2017 year-over-year; TTM through Dec 2017 was $3.7 million, a 83.12% decrease, with the full-year FY2023 number at $3000.0, up 229.14% from a year prior.
  • Cash from Investing Activities hit $1.1 million in Q4 2017 for Tenax Therapeutics, up from $756129.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for TENX hit a ceiling of $35.0 million in Q2 2015 and a floor of -$34.6 million in Q3 2014.
  • Historically, Cash from Investing Activities has averaged $1.7 million across 5 years, with a median of $778315.0 in 2017.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 104185.66% in 2014 and later soared 891.68% in 2016.
  • Tracing TENX's Cash from Investing Activities over 5 years: stood at -$35711.0 in 2013, then crashed by 96724.38% to -$34.6 million in 2014, then skyrocketed by 113.84% to $4.8 million in 2015, then soared by 158.72% to $12.4 million in 2016, then crashed by 90.93% to $1.1 million in 2017.
  • Business Quant data shows Cash from Investing Activities for TENX at $1.1 million in Q4 2017, $756129.0 in Q3 2017, and $800501.0 in Q2 2017.